Topics

FDA approves Celltrion, Teva's Truxima as first biosimilar of Roche's Rituxan in the US http://bit.ly/2BCDZ4q  $TEVA #FDA #pharma

16:47 EST 28 Nov 2018 | FirstWord Pharma

FDA approves Celltrion, Teva's Truxima as first biosimilar of Roche's Rituxan in the US http://bit.ly/2BCDZ4q 

Original Article: FDA approves Celltrion, Teva's Truxima as first biosimilar of Roche's Rituxan in the US http://bit.ly/2BCDZ4q  $TEVA #FDA #pharma

NEXT ARTICLE

More From BioPortfolio on "FDA approves Celltrion, Teva's Truxima as first biosimilar of Roche's Rituxan in the US http://bit.ly/2BCDZ4q  $TEVA #FDA #pharma"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...